PMV Pharmaceuticals share price logo

PMV Pharmaceuticals

NASDAQ: PMVP

$1.40

-0.04

(-2.78%)

as on

PMV Pharmaceuticals Stock Performance

as on September 12, 2026 at 2:15 pm IST

  • Day's High

    $1.40
    $1.50

    7.14%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.02
    $1.88
    downward going graph

    27.14%

    Downside

    34.29%

    Upside

    downward going graph

PMV Pharmaceuticals share price movements today

Previous Close
$1.44
Open
$1.43
Volume
930.6K
Market Cap
$71.6M
Day's Low - High
$1.40 - $1.50
52 Week Low - High
$1.02 - $1.88

PMV Pharmaceuticals Historical Returns

1 Month Return
+ 11.79 %
3 Month Return
+ 29.72 %
1 Year Return
+ 8.27 %
3 Year Return
-77.31 %
5 Year Return
-95.53 %

PMV Pharmaceuticals Stock Fundamentals & Key Indicators

Check PMV Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$71.6M

EPS (TTM)

-1.2833

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-79.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-70.93%

PMV Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PMV Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$71.6M-95.53%NA0.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$138.4B181.2%30.5486.04%NA
BUY$56.0B-69.82%-16.99-12.57%NA
BUY$85.2B24.16%19.2884.86%45.660000000000004%

Stock Returns calculator for PMV Pharmaceuticals Stock including INR - Dollar returns

The PMV Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

PMV Pharmaceuticals investment value today

Current value as on today

₹1,19,306

Returns

₹19,306

(+19.31%)

Returns from PMV Pharmaceuticals Stock

₹10,236 (+10.24%)

Dollar Impact

₹9,070 (+9.07%)

Analyst Recommendation on PMV Pharmaceuticals Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for PMV Pharmaceuticals. Average target price of $4.2

PMV Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on PMV Pharmaceuticals.

What analysts predicted

66.67%UPSIDE

Target Price

$4.2

Current Price

$1.4

Analyzed by

5 Analysts

Target

$4.20

PMV Pharmaceuticals target price $4.2, a slight upside of 66.67% compared to current price of $1.4. According to 5 analysts rating.

Indian Investors' Interest in PMV Pharmaceuticals Stock

Search interest for PMV Pharmaceuticals Stock has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-27% versus previous 30 day period

PMV Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
0
0
0
0
-
Operating Income
-18
-20
-21
-25
-21
-22
-22
-19
-19
-18
EBITDA
-14
-17
-18
-22
-19
-21
-21
-17
-18
-18
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-15
-17
-19
-23
-19
-21
-21
-18
-18
-18
Income Tax Expense
0
-16
0
-
-2
0
0
0
-
0
Net Income
-15
-1
-19
-23
-17
-21
-21
-18
-18
-18
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PMV Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-1
0
-1
-1
0
Operating Income
-18
-26
-34
-58
-77
-80
-85
-86
EBITDA
-18
-24
-34
-57
-76
-67
-73
-79
Interest Expense
-
1
0
0
4
-
-
-
Depreciation
0
0
0
0
0
0
1
0
Income Before Tax
-17
-25
-34
-57
-73
-68
-74
-79
Income Tax Expense
0
0
0
0
0
0
-16
-2
Net Income
-17
-25
-34
-57
-73
-68
-58
-77
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PMV Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
-19
-23
-17
-21
-21
-18
-18
-18
Operating Cash Flow
-1
-16
-16
-18
-18
-19
-17
-19
-14
Investing Cash Flow
2
17
7
28
10
12
18
20
-12
Financing Cash Flow
0
-
0
0
0
-
0
-
0
Change in Cash
0
0
-8
10
-7
-7
1
1
-26

PMV Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-25
-34
-57
-73
-68
-58
-77
Operating Cash Flow
-22
-32
-46
-63
-55
-51
-73
Investing Cash Flow
3
27
-143
-1
-50
53
70
Financing Cash Flow
61
292
2
0
35
0
0
Change in Cash
42
288
-188
-64
-70
2
-2

Mutual Funds that own PMV Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in PMV Pharmaceuticals.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.570584%
1941127
Meridian Fund Inc
1.428785%
1078920
Bridgeway Funds, Inc.
0.540771%
408353
Fidelity Concord Street Trust
0.483236%
364907
TIAA-CREF Funds
0.181167%
136805

Global Institutional Holdings in PMV Pharmaceuticals

Funds
Holdings
Vanguard
2.57%
iShares
0.21%
Bridgeway
0.1%
James E. Flynn
0.01%
Avantis
0.01%

PMV Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 31 August

    Tue, 01:35 AM

    -

    PMV Pharmaceuticals announces completion of enrollment for Phase 2 ovarian cancer trial and plans NDA submission in Q1 2027.

    Tue, 01:35 AM

    -

    PMV Pharmaceuticals initiates underwritten public offering of common stock and warrants.

    Tue, 02:00 AM

    -

    PMV Pharmaceuticals reports promising Phase 2 ovarian cancer data with 46% overall response rate.

Insights on PMV Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PMVP stock has moved up by 8.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 512.4% return, outperforming this stock by 498.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 36.8% return, outperforming this stock by 114.9%

About PMV Pharmaceuticals

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
OrganisationPMV Pharmaceuticals
Headquarters400 Alexander Park Drive, Princeton, NJ, United States, 08540
IndustryBiotechnology
CEODr. David H. Mack Ph.D.
E-voting on sharesClick here to vote

Key Management of PMV Pharmaceuticals

Name

Title

Dr. Arnold J. Levine Ph.D.

Co-Founder, Independent Director & Member of Scientific Advisory Board

Mr. Robert Ticktin J.D.

General Counsel, COO & Company Secretary

Mr. Tim Smith M.B.A.

Senior VP and Head of Corporate Development & Investor Relations

Dr. Binh Vu Ph.D.

Senior Vice President of Drug Discovery & CMC

Dr. David H. Mack Ph.D.

Co-Founder, CEO, President & Director

Dr. Deepika Jalota Pharm.D.

Chief Development Officer

Mr. Michael Carulli

Chief Financial Officer

Ms. Crystal Zuckerman

Vice President of Human Resources

Dr. Marc Fellous M.D.

Senior VP and Head of Clinical Development & Medical Affairs

Ms. Laura De Leon

VP & Head of Clinical Development Operations

FAQs

What is PMV Pharmaceuticals share price today?

PMV Pharmaceuticals share price today is $1.40 as on at the close of the market. PMV Pharmaceuticals share today touched a day high of $1.50 and a low of $1.40.

What is the 52 week high and 52 week low for PMV Pharmaceuticals share?

PMV Pharmaceuticals share touched a 52 week high of $1.88 on and a 52 week low of $1.02 on . PMV Pharmaceuticals stock price today i.e. is closed at $1.40,which is 25.53% down from its 52 week high and 37.25% up from its 52 week low.

What is PMV Pharmaceuticals's market capitalisation today?

PMV Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in PMV Pharmaceuticals Stock (PMVP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PMV Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PMV Pharmaceuticals Shares that will get you 1.0714 shares as per PMV Pharmaceuticals share price of $1.40 per share as on September 12, 2026 at 8:45 am IST.

What is the minimum amount required to buy PMV Pharmaceuticals Stock (PMVP) from India?

Indian investors can start investing in PMV Pharmaceuticals (PMVP) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in PMV Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on PMV Pharmaceuticals share’s latest price of $1.40 as on September 12, 2026 at 8:45 am IST, you will get 7.1429 shares of PMV Pharmaceuticals. Learn more about fractional shares .

What are the returns that PMV Pharmaceuticals has given to Indian investors in the last 5 years?

PMV Pharmaceuticals stock has given -95.53% share price returns and 29.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?